{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:54:18Z","timestamp":1770749658088,"version":"3.50.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Case Reports"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jaccas.2025.104036","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T22:25:55Z","timestamp":1752618355000},"page":"104036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Digenic Overlap Syndrome Masquerading as Homozygous Familial Hypercholesterolemia"],"prefix":"10.1016","volume":"30","author":[{"given":"Samuel D.","family":"Maidman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2632-6669","authenticated-orcid":false,"given":"Chen","family":"Gurevitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5599-0633","authenticated-orcid":false,"given":"Robert S.","family":"Rosenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.jaccas.2025.104036_bib1","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1016\/j.jacc.2020.03.057","article-title":"Worldwide prevalence of familial hypercholesterolemia: meta-analyses of 11 million subjects","volume":"75","author":"Beheshti","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jaccas.2025.104036_bib2","doi-asserted-by":"crossref","first-page":"791","DOI":"10.5551\/jat.RV17052","article-title":"Diagnosis and management of sitosterolemia 2021","volume":"28","author":"Tada","year":"2021","journal-title":"J Atheroscler Thromb"},{"issue":"5","key":"10.1016\/j.jaccas.2025.104036_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11883-023-01092-4","article-title":"Update on sitosterolemia and atherosclerosis","volume":"25","author":"Rocha","year":"2023","journal-title":"Curr Atheroscler Rep"},{"issue":"6","key":"10.1016\/j.jaccas.2025.104036_bib4","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jacc.2018.05.044","article-title":"Clinical genetic testing for familial hypercholesterolemia: JACC Scientific Expert Panel","volume":"72","author":"Sturm","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"45","key":"10.1016\/j.jaccas.2025.104036_bib5","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jaccas.2025.104036_bib6","article-title":"Competing genetic traits and their influence on LDL cholesterol concentration in familial hypercholesterolemia","volume":"29","author":"Song","year":"2024","journal-title":"JACC Case Rep"},{"issue":"22","key":"10.1016\/j.jaccas.2025.104036_bib7","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1161\/CIR.0000000000000297","article-title":"The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association","volume":"132","author":"Gidding","year":"2015","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jaccas.2025.104036_bib8","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jamacardio.2019.5954","article-title":"Association of monogenic vs polygenic hypercholesterolemia with risk of atherosclerotic cardiovascular disease","volume":"5","author":"Trinder","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"22","key":"10.1016\/j.jaccas.2025.104036_bib9","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia","volume":"67","author":"Khera","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.jaccas.2025.104036_bib10","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.jacc.2022.07.006","article-title":"2022 ACC expert consensus decision pathway on the role of nonstatin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American College of Cardiology solution set oversight committee","volume":"80","author":"Writing","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"10.1016\/j.jaccas.2025.104036_bib11","first-page":"e771","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"151","author":"Rao","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.jaccas.2025.104036_bib12","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa2031049","article-title":"Evinacumab in patients with refractory hypercholesterolemia","volume":"383","author":"Rosenson","year":"2020","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.jaccas.2025.104036_bib13","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.jacc.2023.02.038","article-title":"Familial hypercholesterolemia: challenges for a high-risk population: JACC Focus Seminar 1\/3","volume":"81","author":"Choi","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"10.1016\/j.jaccas.2025.104036_bib15","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1161\/CIRCULATIONAHA.118.035658","article-title":"Whole-genome sequencing to characterize monogenic and polygenic contributions in patients hospitalized with early-onset myocardial infarction","volume":"139","author":"Khera","year":"2019","journal-title":"Circulation"},{"issue":"5497","key":"10.1016\/j.jaccas.2025.104036_bib16","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1126\/science.290.5497.1771","article-title":"Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters","volume":"290","author":"Berge","year":"2000","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jaccas.2025.104036_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.6065\/apem.2016.21.1.7","article-title":"Sitosterolemia: a review and update of pathophysiology, clinical spectrum, diagnosis, and management","volume":"21","author":"Yoo","year":"2016","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jaccas.2025.104036_bib19","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jacl.2017.04.116","article-title":"Sitosterolemia: a multifaceted metabolic disorder with important clinical consequences","volume":"11","author":"Tzavella","year":"2017","journal-title":"J Clin Lipidol"},{"issue":"2","key":"10.1016\/j.jaccas.2025.104036_bib20","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.atherosclerosis.2013.09.038","article-title":"Non-cholesterol sterols and cholesterol metabolism in sitosterolemia","volume":"231","author":"Othman","year":"2013","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.jaccas.2025.104036_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238079","article-title":"High prevalence of increased sitosterol levels in hypercholesterolemic children suggest underestimation of sitosterolemia incidence","volume":"15","author":"Lee","year":"2020","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jaccas.2025.104036_bib22","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1161\/01.CIR.0000116766.31036.03","article-title":"Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia","volume":"109","author":"Salen","year":"2004","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.jaccas.2025.104036_bib23","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1001\/jama.2016.3608","article-title":"Efficacy and tolerability of evolocumab vs ezetimibe in patients with muscle-related statin intolerance: the GAUSS-3 randomized clinical trial","volume":"315","author":"Nissen","year":"2016","journal-title":"JAMA"},{"issue":"25","key":"10.1016\/j.jaccas.2025.104036_bib24","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.jaccas.2025.104036_bib25","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/j.1742-1241.2008.01841.x","article-title":"Long-term efficacy and safety of ezetimibe 10 mg in patients with homozygous sitosterolemia: a 2-year, open-label extension study","volume":"62","author":"Lutjohann","year":"2008","journal-title":"Int J Clin Pract"},{"issue":"11","key":"10.1016\/j.jaccas.2025.104036_bib26","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.cjca.2013.08.003","article-title":"Incremental lowering of low-density lipoprotein cholesterol with ezetimibe 20 mg vs 10 mg daily in patients receiving concomitant statin therapy","volume":"29","author":"Ziada","year":"2013","journal-title":"Can J Cardiol"}],"container-title":["JACC: Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084925008174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084925008174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T22:26:44Z","timestamp":1752618404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666084925008174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":24,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2666084925008174"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccas.2025.104036","relation":{},"ISSN":["2666-0849"],"issn-type":[{"value":"2666-0849","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Digenic Overlap Syndrome Masquerading as Homozygous Familial Hypercholesterolemia","name":"articletitle","label":"Article Title"},{"value":"JACC: Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccas.2025.104036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"104036"}}